CD274 and neoplasm: For example, using a nanoplatform to deliver both neoantigen and interferon gene stimulation pathway activator, researchers significantly suppressed tumor growth in 4T1 breast cancer mice and produced robust anti-tumor effects in combination with PD-L1 inhibitors (Zhou et al., 2020).